Dublin, Ireland, June 16, 2006. ICON (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has entered into a definitive agreement to acquire Ovation Research Group, a leading patient registries, outcomes research and health economics firm
